BNP Paribas Financial Markets’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.94K | Buy |
6,717
+6,016
| +858% | +$8.9K | ﹤0.01% | 4028 |
|
|
2025
Q1 | $1.8K | Sell |
701
-15
| -2% | -$38 | ﹤0.01% | 4162 |
|
|
2024
Q4 | $1.35K | Buy |
+716
| New | +$1.35K | ﹤0.01% | 4199 |
|
|
2015
Q4 | – | Sell |
-6,177
| Closed | -$72.9K | – | 3623 |
|
|
2015
Q3 | $72.9K | Sell |
6,177
-1,105
| -15% | -$13K | ﹤0.01% | 2603 |
|
|
2015
Q2 | $142K | Sell |
7,282
-1,468
| -17% | -$28.6K | ﹤0.01% | 1894 |
|
|
2015
Q1 | $156K | Sell |
8,750
-3,406
| -28% | -$60.6K | ﹤0.01% | 1621 |
|
|
2014
Q4 | $224K | Sell |
12,156
-8,714
| -42% | -$160K | ﹤0.01% | 1332 |
|
|
2014
Q3 | $505K | Buy |
20,870
+8,100
| +63% | +$196K | ﹤0.01% | 1324 |
|
|
2014
Q2 | $466K | Sell |
12,770
-4,075
| -24% | -$149K | ﹤0.01% | 1292 |
|
|
2014
Q1 | $682K | Buy |
16,845
+795
| +5% | +$32.2K | ﹤0.01% | 1167 |
|
|
2013
Q4 | $624K | Buy |
16,050
+4,050
| +34% | +$158K | ﹤0.01% | 1029 |
|
|
2013
Q3 | $544K | Buy |
+12,000
| New | +$544K | ﹤0.01% | 1267 |
|